Tatiana Golovina

Tatiana Golovina is an experienced professional in the field of cell and gene therapy development. She currently serves as the Senior Vice President Development at BlueWhale Bio, a position she has held since September 2023.1 In this role, she is leading the development of a platform that aims to address manufacturing challenges in efficacy, durability, and cost for the next generation of cell and gene therapies.1

Professional Background

Tatiana has over 20 years of experience in various aspects of cell therapy development, including:

• Analytical development
• Target and assay validation
• Early and late process development
• Regulatory document preparation
• Translational research
• T lymphocyte research
• Protein purification and characterization

Her expertise also extends to risk assessment, change control, process change implementation, and technology transfer.1

Career Progression

Before joining BlueWhale Bio, Tatiana held several notable positions:

• Executive Director Cell Therapy at WuXi Advanced Therapies (October 2020 - September 2023)
• Senior Director Cell Therapy at WuXi Advanced Therapies (October 2019 - October 2020)
• Director Cell Therapy, Process and Technology Development at WuXi Advanced Therapies (October 2018 - October 2019)

She has also worked as a Fellow in Process Development for Cell & Gene Therapy and as a Project Manager at the University of Pennsylvania.1

Education

Tatiana holds a Doctor of Philosophy (PhD) in Bioorganic Chemistry from the Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry, which she completed between 1991 and 1996. She also has a Master of Science (MS) in Biology from Lomonosov Moscow State University (MSU), obtained between 1979 and 1984.1

Skills and Expertise

Tatiana's multidisciplinary experience spans the entire development process "from bench to launch" in cell therapy. Her background in immunology, project management, and translational research has equipped her with a comprehensive understanding of the field.1